Molecular Templates, Inc. Quarterly report pursuant to Section 13 or 15(d)

Quarterly report pursuant to Section 13 or 15(d)

Net Loss Per Common Share

Net Loss Per Common Share

6 Months Ended

Jun. 30, 2019

NOTE 2 — NET LOSS PER COMMON SHARE

Basic net loss per common share is computed by dividing net loss by the weighted-average number of common shares outstanding during the period. Diluted net loss per share is computed by giving effect to all potential dilutive common shares, including outstanding options and warrants. The following is the calculation of basic and diluted net loss per share (in thousands, except share and per share data):

	Three Months Ended June 30,				Six Months Ended June 30,
	2019		2018		2019		2018
Net loss attributable to common shareholders:	$	9,153	$	9,695	$	15,321	$	18,409
Weighted average common shares outstanding - basic and diluted		36,819,846		27,062,440		36,779,638		27,026,263
Net loss per share attributable to common shareholders:
Basic and diluted	$	0.25	$	0.36	$	0.42	$	0.68

The following outstanding warrants and options were excluded from the computation of diluted net loss per share for the periods presented because including them would have had an antidilutive effect (in thousands):

	June 30,
	2019		2018
Shares issuable upon exercise of warrants		3,522		3,522
Shares issuable upon exercise of stock options		5,106		4,347